← Juewei Food overview

Juewei Food vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Juewei Food Co Ltd (603517.CG)

Q3 2026
▼3▲1

Weak earnings and stalled asset sale offset buyback and dividend support

  • Profit and revenue decline, cash flow turns negative First-half net profit fell 23% to 135 million yuan and revenue dropped 10.8% to 2.515 billion yuan. Operating cash flow swung to negative 182 million yuan, a huge deterioration. This weak core business pressures the stock because it shows the company is selling less and collecting less cash.

    The interim report is the clearest evidence of fundamental weakness driving the stock down.

  • Saifeiya stake sale hits payment snag The buyer of ST Juewei's 24.17% stake in loss-making Saifeiya missed the first payment deadline. The 84.58 million yuan exit is now uncertain, meaning the company may stay tied to a long-time money-loser and not get the cash it expected.

    This is a new negative event that threatens a planned cash inflow and adds uncertainty.

  • More related-party deals with a loss-making associate ST Juewei raised its 2026 related-party transaction quota by 25 million yuan, all tied to Sichuan Liaoji, an associate with negative net assets and a first-half loss. This raises concerns about cash being diverted to a struggling partner while the company's own finances weaken.

    It shows a new governance and capital-allocation risk that can weigh on investor confidence.

  • Buyback and dividend return cash to shareholders ST Juewei is buying back 100-200 million yuan of stock and paying a 0.25 yuan per share dividend. By September 30 it had already repurchased about 8.5 million shares for roughly 100 million yuan. These actions support the share price by reducing shares outstanding and returning cash.

    These are the main positive forces offsetting the weak earnings and asset-sale problems.

September 2026
▼3▲1

Weak earnings and stalled asset sale offset buyback and dividend support

  • Profit and revenue decline, cash flow turns negative First-half net profit fell 23% to 135 million yuan and revenue dropped 10.8% to 2.515 billion yuan. Operating cash flow swung to negative 182 million yuan, a huge deterioration. This weak core business pressures the stock because it shows the company is selling less and collecting less cash.

    The interim report is the clearest evidence of fundamental weakness driving the stock down.

  • Saifeiya stake sale hits payment snag The buyer of ST Juewei's 24.17% stake in loss-making Saifeiya missed the first payment deadline. The 84.58 million yuan exit is now uncertain, meaning the company may stay tied to a long-time money-loser and not get the cash it expected.

    This is a new negative event that threatens a planned cash inflow and adds uncertainty.

  • More related-party deals with a loss-making associate ST Juewei raised its 2026 related-party transaction quota by 25 million yuan, all tied to Sichuan Liaoji, an associate with negative net assets and a first-half loss. This raises concerns about cash being diverted to a struggling partner while the company's own finances weaken.

    It shows a new governance and capital-allocation risk that can weigh on investor confidence.

  • Buyback and dividend return cash to shareholders ST Juewei is buying back 100-200 million yuan of stock and paying a 0.25 yuan per share dividend. By September 30 it had already repurchased about 8.5 million shares for roughly 100 million yuan. These actions support the share price by reducing shares outstanding and returning cash.

    These are the main positive forces offsetting the weak earnings and asset-sale problems.

Latest
▼3▲1

Weak earnings and stalled asset sale offset buyback and dividend support

  • Profit and revenue decline, cash flow turns negative First-half net profit fell 23% to 135 million yuan and revenue dropped 10.8% to 2.515 billion yuan. Operating cash flow swung to negative 182 million yuan, a huge deterioration. This weak core business pressures the stock because it shows the company is selling less and collecting less cash.

    The interim report is the clearest evidence of fundamental weakness driving the stock down.

  • Saifeiya stake sale hits payment snag The buyer of ST Juewei's 24.17% stake in loss-making Saifeiya missed the first payment deadline. The 84.58 million yuan exit is now uncertain, meaning the company may stay tied to a long-time money-loser and not get the cash it expected.

    This is a new negative event that threatens a planned cash inflow and adds uncertainty.

  • More related-party deals with a loss-making associate ST Juewei raised its 2026 related-party transaction quota by 25 million yuan, all tied to Sichuan Liaoji, an associate with negative net assets and a first-half loss. This raises concerns about cash being diverted to a struggling partner while the company's own finances weaken.

    It shows a new governance and capital-allocation risk that can weigh on investor confidence.

  • Buyback and dividend return cash to shareholders ST Juewei is buying back 100-200 million yuan of stock and paying a 0.25 yuan per share dividend. By September 30 it had already repurchased about 8.5 million shares for roughly 100 million yuan. These actions support the share price by reducing shares outstanding and returning cash.

    These are the main positive forces offsetting the weak earnings and asset-sale problems.

Danone SA (BN.PA)

Q3 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

July 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Latest
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.